Lyell Immunopharma, Inc. (LYEL) SEC Filings — 2025
19 SEC filings for Lyell Immunopharma, Inc. (LYEL) in 2025.
Filings
- Lyell Immunopharma Files 8-K for Other Event — 8-K · Dec 8, 2025
- Lyell Immunopharma, Inc. 8-K Filing — 8-K · Dec 5, 2025
- Lyell Narrows Losses Amid R&D Cuts, Boosts Cash with PIPE Financing — 10-Q · Nov 12, 2025
- Lyell Immunopharma, Inc. 8-K Filing — 8-K · Nov 10, 2025
- Lyell Immunopharma Files 8-K on Executive Changes — 8-K · Nov 3, 2025
- Lyell Immunopharma Reports Leadership Changes — 8-K · Sep 16, 2025
- Lyell Narrows Losses Amid R&D Cuts, Cash Burn Continues — 10-Q · Aug 12, 2025
- Lyell Immunopharma Files 8-K on Material Agreement — 8-K · Jul 25, 2025
- Lyell Immunopharma Reports Unregistered Equity Sales — 8-K · Jun 26, 2025
- Lyell Immunopharma Files 8-K Report — 8-K · Jun 17, 2025
- Lyell Immunopharma Announces Board and Executive Changes — 8-K · Jun 9, 2025
- Lyell Immunopharma Files 8-K — 8-K · May 28, 2025
- Lyell Immunopharma Files 8-K on Shareholder Votes — 8-K · May 21, 2025
- Lyell Immunopharma Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Lyell Immunopharma Files Definitive Proxy Statement — DEF 14A · Apr 21, 2025
- Lyell Immunopharma Files 8-K on Corporate Changes — 8-K · Apr 1, 2025
- Lyell Immunopharma Files 2024 10-K — 10-K · Mar 11, 2025
- Lyell Immunopharma Fails Nasdaq Listing Standards — 8-K · Jan 24, 2025
- Lyell Immunopharma Files 8-K Amendment — 8-K/A · Jan 10, 2025